Nobel Biocare India Profile
Key Indicators
- Authorised Capital ₹ 4.50 M
- Paid Up Capital ₹ 0.32 M
- Company Age 20 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 16.69%
- Profit Growth 274.61%
- Ebitda 513.83%
- Net Worth 23.12%
- Total Assets 16.66%
About Nobel Biocare India
Nobel Biocare India Private Limited (NBIPL) is a leading Private Limited Foreign Company Incorporated In India incorporated in India on 29 December 2004 and has a history of 20 years and one month. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.50 M and a paid-up capital of Rs 0.32 M, as per Ministry of Corporate Affairs (MCA) records.
Sweta Mishra, Tanmay Goyal, and Priya Barthwal serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U51397MH2004FTC150267
- Company No.
150267
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
29 Dec 2004
- Date of AGM
28 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Nobel Biocare India?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sweta Mishra  | Director | 28-Jun-2023 | Current |
| Tanmay Goyal | Director | 26-Sep-2019 | Current |
| Priya Barthwal | Director | 05-Feb-2021 | Current |
Financial Performance of Nobel Biocare India.
Nobel Biocare India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16.69% increase. The company also saw a substantial improvement in profitability, with a 274.61% increase in profit. The company's net worth Soared by an impressive increase of 23.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nobel Biocare India?
In 2023, Nobel Biocare India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nobel Biocare India?
Nobel Biocare India has a workforce of 79 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nobel Biocare India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nobel Biocare India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
